NCT02604771View on ClinicalTrials.gov

Egypt Hypertension Study

CompletedOBSERVATIONAL

Enrollment

1,500

Participants

Timeline

Start Date

April 3, 2016

Primary Completion Date

February 14, 2018

Study Completion Date

February 14, 2018

Conditions

Different Classes of the Antihypertensive Treatment

Trial Locations (1)

Unknown

Research Site, Egypt

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY